Challenges of management and therapy in patients with a functionally single ventricle after Fontan operation

Cardiology Journal

Volumn 18, Issue 2, 2011, Pages 119-127

  Trojnarska, Olga ^a   Cieplucha, Aleksandra ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Complications; Fontan operation; Long term follow up; Management

Indexed keywords

ALDOSTERONE RECEPTOR; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; COUMARIN DERIVATIVE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INOTROPIC AGENT; LOOP DIURETIC AGENT; NESIRITIDE; PHOSPHODIESTERASE INHIBITOR; PREDNISOLONE; SPIRONOLACTONE; UROKINASE;

ARTICLE; BLOOD OXYGENATION; CLINICAL EFFECTIVENESS; COLLATERAL CIRCULATION; CONNECTIVE TISSUE DISEASE; CYANOSIS; DIET SUPPLEMENTATION; FONTAN PROCEDURE; HEART FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART OUTPUT; HEART SINGLE VENTRICLE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; HYPOCALCEMIA; LIVER DYSFUNCTION; PORTAL VEIN BLOOD PRESSURE; PREGNANCY; PROTEIN LOSING GASTROENTEROPATHY; PULMONARY ARTERY MALFORMATION; SURGICAL TECHNIQUE; THROMBOEMBOLISM;

ARRHYTHMIAS, CARDIAC; FONTAN PROCEDURE; HEART FAILURE; HUMANS; PALLIATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROTEIN-LOSING ENTEROPATHIES; THROMBOEMBOLISM;

EID: 79952836498     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax, 1971; 26: 240-248.
2. Khairy P, Poirier N, Mercier LA. Univentricular heart. Circulation, 2007; 115: 800-812.
3. Robicsek F, Watts LT. A prelude to Fontan. Pediatric Cardiol, 2007; 28: 422-425.
4. Jensen RA, Williams RG, Laks H et al. Usefulness of banding of the pulmonary trunk with single ventricle physiology at risk for subaortic obstruction. Am J Cardiol, 1996; 77: 1089-1093.
5. Choussat A, Fontan F, Besse B et al. Selection criteria for Fontan's procedure. In: Anderson RH, Shinebourne EA eds. Paediatric cardiology. Churchill Livingstone, New York 1978: 559-566.
6. de Leval MR, Kilner P, Gewiling M et al. Total cavopulmonary connection: A logical alternative to atriopulmonary connection for complex Fontan operations: Experimental studies and early clinical experience. J Thorac Cardiovasc Surg, 1988; 96: 682-695.
7. Marcelletti C, Corno A, Giannico S et al. Inferior vena cavapulmonary artery extracardiac conduit: A new form of right heart bypass. J Thorac Cardiovasc Surg, 1990; 100: 228-231.
8. Bridges ND, Mayer JE, Lock JE et al. Effect of baffle fenestration on outcome of the modified Fontan operation. Circulation, 1992; 86: 1762-1769.
9. Dick M, Fyler DC, Nadas AS. Tricuspid atresia: Clinical course in 101 patients. Am J Cardiol, 1975; 36: 327-337.
10. Landzberg MJ, Murphy DJ, Davidson WR et al. Task force 4: Organization of delivery system for adults with congenital heart disease. J Am Coll Cardiol, 2001; 37: 1187-1193.
11. Moodie DS, Ritter DG, Tajik AJ et al. Long-term follow-up in the unoperated univentricular heart. Am J Cardiol, 1984; 53: 1124-1128.
12. Earing MG, Cetta F, Driscoll DJ et al. Long term results of the Fontan operation for double-inlet left ventricle. Am J Cardiol, 2005; 96: 291-298.
13. Stamm C, Friehs I, Mayer JE et al. Long term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg, 2001; 121: 28-41.
14. Khairy P, Fernandes SM, Mayer JE et al. Long term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation, 2008; 117: 85-92.
15. Weipert J, Noebauer C, Schreiber C et al. Occurrence and management of atrial arrhythmia after long-term Fontan circulation. J Thorac Cardiovasc Surg, 2004; 127: 457-464.
16. Deal BJ, Mavroudis C, Backer CL. Arrhythmia management in the Fontan patient. Pediatr Cardiol, 2007; 28: 448-456.
17. Sanchez-Quintana D, Climent V, Ho SY et al. Myoarchitecture and connective tissue in hearts with tricuspid atresia. Heart, 1999; 81: 182-191.
18. Fischberger SB, Wernowsky G, Gentles TL et al. Factors that influence the development of atrial flutter after the Fontan operation. J Thorac Cardiovasc Surg, 1997; 113: 80-86.
19. Durongpistikul K, Porter CJ, Cetta F et al. Predictors of earlyand late-onset supraventricular tachyarrhythmias after Fontan operation. Circulation, 1998; 98: 1099-1107.
20. Ashburn DA, Harris L, Downar EH et al. Electrophysiologic surgery in patients with congenital heart disease. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, 2003; 6: 51-58.
21. Trojnarska O. Adolescent with congenital heart diseases. Cardiol J, 2010; 17: 11-19.
22. Walsh EP, Cecchin F. Arrhythmias in adult patients with congenital heart disease. Circulation, 2007; 115: 534-545.
23. Thorne SA. Pregnancy in heart disease. Heart, 2004; 90: 450-456.
24. Gersony DR, Gersony WM. Management of the postoperative Fontan patients. Progress Ped Card, 2003; 17: 73-79.
25. Ghanayem NS, Berger S, Tweddell JS. Medical management of the failing Fontan. Pediatr Cardiol, 2007; 28: 465-471.
26. Triedman JK, Alexander ME, Love BA et al. Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol, 2002; 39: 1827-1835.
27. Kennankeril PJ, Anderson ME, Rottman JN et al. Frequency of late recurrence of intra-atrial reentry tachycardia after radiofrequency catheter ablation in patients with congenital heart disease. Am J Cardiol, 2003; 92: 879-881.
28. Mavroudis C, Deal BJ, Backer CL et al. The beneficial effects of cavo-pulmonary conversion and arrhythmia surgery for the failed Fontan. Semin Thiorac Cardiovasc Surg Pediatr Cadr Surg Ann, 2002; 5: 12-24.
29. Setty SP, Finucane F, Skinner JR et al. Extracardiac conduit with a limited maze procedure for the failing Fontan with atrial tachycardias. Ann Thorac Surg, 2002; 74: 1992-1997.
30. Collins KK, Love BA, Walsh EP et al. Location of acutely successful radiofrequency catheter ablation of intraatrial re-entrant tachycardia in patients with congenital heart disease. Am J Cardiol, 2000; 86: 969-974.
31. Heinemann MK, Gass M, Breuer J et al. DDD pacemaker implantation after Fontan-type operations. PACE, 2003; 26: 492-496.
32. Hansky B, Blanz U, Peuster M et al. Endocardial pacing after Fontan-type procedures. Pacing Clin Electrophysiol, 2005; 28: 140-148.
33. Jacobs ML, Pourmoghadam KK. Thromboembolism and the role of anticoagulation in the Fontan patients. Pediatr Cardiol, 2007; 28: 457-464.
34. Chun DS, Schamberger MS, Flaspohler T et al. Incidence, outcome, and risk factors for stroke after Fontan procedure. Am J Cardiol, 2004; 93: 117-119.
35. Jacobs ML, Pourmoghadam KK, Geary EM et al. Fontan's operation: Is aspirin enough? Is coumadin too much? Ann Thorac Surg, 2002; 73: 64-68.
36. Madan N, Robinson BW, Jacobs ML. Thrombosis in the proximal pulmonary artery stump in a Fontan patient. Heart, 2002; 88: 396-399.
37. Monagle P, Karl TR. Thromboembolic problems after the Fontan operation. Pediatr Cardiac Surg Annu Sem Thorac Cardiovasc Surg, 2002; 5: 36-44.
38. Seipelt RG, Franke A, Vazquez-Jimenez JF. Thromboembolic complications after Fontan procedures: Comparison of different therapeutic approaches. Ann Thorac Surg, 2002; 74: 556-563.
39. Mertens L, Haggler DJ, Sauer U et al. Perioperative risk factors for development of protein-losing enteropathy following Fontan procedure: An international multicenter study. PLE study group. J Thorac Cardiovasc Surg, 1998; 115: 1063-1073.
40. Powell AJ, Gauvreau K, Jenkins KL et al. Perioperative risk factors for development of protein-losing enteropathy following Fontan procedure. Am J Cardiol, 2001; 88: 1206-1209.
41. Driscoll DJ. Long-term results of the Fontan operation. Pediatr Cardiol, 2007; 28: 438-442.
42. Lenz D, Hambsch J, Schneider P et al. Protein-losing enteropathy in patients after Fontan circulation: Is it triggered by infection? Crit Care, 2003; 7: 185-190.
43. Rychik J, Spray TL. Strategies to treat protein-losing enteropathy. Semin Thorac Cardiovasc Surg Pediatr Cardiac Surg Ann, 2002; 5: 3-11.
44. Guariso G, Cerutti A, Mareolo GS et al. Protein-losing enteropathy after Fontan operation: Treatment with elementary diet in one case. Pediatr Cardiol, 2000; 21: 292.
45. Ringel RE, Peddy SB. Effect of high-dose spironolactone on protein--losing enteropathy in patients with Fontan palliation of complex congenital heart disease. Am Coll Cardiol, 2003; 91: 1031-1032.
46. Therrien J, Webb GD, Gatzoulis MA. Reversal of protein-losing enteropathy with prednisolone in adults with modified Fontan operation: Long-term palliation or bridge to cardiac transplantation? Heart, 1999; 82: 241-243.
47. Bendayan I, Casaldaliga J, Castello F et al. Heparin therapy and reversal of protein-losing enteropathy in a case with congenital heart disease. Pediatr Cardiol, 2000; 21:267-268.
48. Kim SJ, Park IS, Song JY et al. Reversal of protein-losing enteropathy with calcium replacement in a patient with Fontan operation. Ann Thorac Surg, 2004; 77: 1456-1457.
49. Chakrabarti S, Keeton BR, Salmon AP et al. Acquired combined immunodeficiency associated with protein losing enteropathy complicating Fontan operation. Heart, 2003; 89: 1130-1131.
50. Piran S, Veldtman G, Siu S et al. Heart failure and ventricle dysfunction in patients with single or systemic right ventricles. Circulation, 2002; 105: 1189-1194.
51. Trojnarska O. Heart failure in adult patients with congenital heart disease. Cardiology J, 2007; 14: 127-137.
52. Durongpisitkul K, Driscoll DJ, Mottram C et al. Cardiopulmonary responses to exercise after modified Fontan operation: A study to determinants of performance. J Am Coll Cardiol, 1997; 29: 785-790.
53. Anderson PA, Sleeper LA, Mahony L et al. Contemporary outcomes after the Fontan procedure. J Am Coll Cardiol, 2008; 52: 85-98.
54. Ohuchi H, Hasegawa S, Yasuda K et al. Severely impaired cardiac autonomic nervous activity after Fontan operation. Circulation, 2001; 104: 1513-1518.
55. Dore A, Houde C, Chan KL et al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricle: A multicenter, randomized, placebo-controlled clinical trial. Circulation, 2005; 112: 2411-2416.
56. Bruns LA, Chrisant MK, Lamour JM et al. Carvedilol as therapy in pediatric heart failure: An initial multicenter experience. J Pediatr, 2001; 138: 505-511.
57. Huddleston CB. The failing Fontan: Options for surgical therapy. Pediatr Cardiol, 2007; 28: 472-476.
58. Holmgren D, Berggren H, Wahlander H et al. Reversal of protein losing enteropathy in a child with Fontan circulation is correlated with central venous pressure after heart transplantation. Pediatr Transplant, 2001; 5: 135-137.
59. Perloff JK, Child JS. Congenital heart disease in adults. 3rd Ed. Saunders Company, Philadelphia 2008: 316-341.
60. Ono M, Boethig D, Goerler H et al. Clinical outcome of patients 20 years after Fontan operation: Effect of fenestration on late mortality. Eur J Cardio-Thorac Surg, 2006; 30: 923-929.
61. Drenthen W, Pieper PG, Ross-Hesselink JW. Pregnancy and delivery in women after Fontan palliation. Heart, 2006; 92: 1290-1294.
62. Canobbio MM, Mair DD, van der Velde M et al. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol, 1996; 28: 736-737.
63. Trojnarska O, Markwitz W, Katarzyński S et al. Pregnancy and delivery in patient after Fontan's operation due to common ventricle of left ventricular morphology. Inter J Cardiol, 2007; 114: e63-e64.
64. Walker F. Pregnancy and the various forms of the Fontan circulation. Heart, 2007; 93: 152-154.